Ken Griffin Enzo Biochem Inc Call Options Transaction History

Citadel Advisors LLC

  • $483 Billion
  • Q2 2024

Call Options

6 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$1.04 - $1.28 $35,360 - $43,520
34,000 New
34,000 $37,000
Q3 2023

Nov 14, 2023
SELL
$1.3 - $1.87 $2,730 - $3,927
-2,100 Reduced 4.86%
41,100 $57,000
Q2 2023

Aug 14, 2023
SELL
$1.84 - $2.66 $6,624 - $9,576
-3,600 Reduced 7.69%
43,200 $79,000
Q1 2023

May 15, 2023
BUY
$1.0 - $2.51 $21,200 - $53,211
21,200 Added 82.81%
46,800 $113,000
Q4 2022

Feb 14, 2023
BUY
$1.16 - $2.42 $16,472 - $34,364
14,200 Added 124.56%
25,600 $36,000
Q3 2022

Nov 14, 2022
BUY
$2.1 - $2.73 $23,940 - $31,122
11,400 New
11,400 $25,000

Others Institutions Holding ENZ

# of Institutions
44
Shares Held
15.2M
Call Options Held
34K
Put Options Held
0
View Full List

About ENZO BIOCHEM INC

ENZ Quotes by TradingView
  • Ticker ENZ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 48,720,500
  • Market Cap $56M
  • Description
  • Enzo Biochem, Inc., an integrated diagnostics, clinical lab, and life sciences company, researches, develops, manufactures, and markets diagnostic and research products based on genetic engineering, biotechnology, and molecular biology. It operates through three segments: Life Sciences Products, Clinical Laboratory Services, and Therapeutics. Th...
More about ENZ
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email